[DOI] [PMC free article] [PubMed] [Google Scholar] Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, DAlessio D, 2000
Practical Nutrition Strategies During and After Discontinuation Protein becomes your strongest ally after stopping GLP-1 medications
For others, they can become chronic and severely affect quality of life
Over 60% of sales in 2025 were via prescription-linked nutrition therapy
Starting with walking, swimming, or low-impact strength training and gradually increasing intensity allows your body to adapt safely while maximizing the metabolic benefits of your medication
Tirzepatide: dual GIP/GLP-1 (Mounjaro, Zepbound) Tirzepatide, marketed under the brand names Mounjaro and Zepbound, is a dual GIP and GLP-1 receptor agonist, representing a new class of diabetes medications